Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer.

Benvenuto G, Todeschini P, Paracchini L, Calura E, Fruscio R, Romani C, Beltrame L, Martini P, Ravaggi A, Ceppi L, Sales G, Donati F, Perego P, Zanotti L, Ballabio S, Grassi T, Marchette MD, Tognon G, Sartori E, Adorni M, Odicino F, D'Incalci M, Bignotti E, Romualdi C, Marchini S.

Int J Cancer. 2020 Feb 25. doi: 10.1002/ijc.32935. [Epub ahead of print]

PMID:
32096871
2.

Health apps targeting children with overweight-a protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials.

Rashid R, Perego P, Condon L, Jakobsen JC, Lindschou J, Gluud C, Andreoni G, Lissau I.

Syst Rev. 2020 Feb 11;9(1):28. doi: 10.1186/s13643-020-1269-0.

3.

Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison.

Fanfani F, Monterossi G, Di Meo ML, La Fera E, Dell'Orto F, Gioè A, Lamanna M, Ferrari D, De Ponti E, Perego P, Restaino S, Carlo R, Zannoni GF, Landoni F, Scambia G, Buda A.

Int J Gynecol Cancer. 2020 Jan 28. pii: ijgc-2019-000937. doi: 10.1136/ijgc-2019-000937. [Epub ahead of print]

PMID:
31996396
4.

Fast Cyclization of a Proline-Derived Self-Immolative Spacer Improves the Efficacy of Carbamate Prodrugs.

Dal Corso A, Borlandelli V, Corno C, Perego P, Belvisi L, Pignataro L, Gennari C.

Angew Chem Int Ed Engl. 2019 Dec 27. doi: 10.1002/anie.201916394. [Epub ahead of print]

PMID:
31881115
5.

Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15.

Mofers A, Perego P, Selvaraju K, Gatti L, Gullbo J, Linder S, D'Arcy P.

PLoS One. 2019 Oct 22;14(10):e0223807. doi: 10.1371/journal.pone.0223807. eCollection 2019.

6.

Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer.

Leonetti A, Sharma S, Minari R, Perego P, Giovannetti E, Tiseo M.

Br J Cancer. 2019 Oct;121(9):725-737. doi: 10.1038/s41416-019-0573-8. Epub 2019 Sep 30. Review.

PMID:
31564718
7.

Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models.

Sartori A, Corno C, De Cesare M, Scanziani E, Minoli L, Battistini L, Zanardi F, Perego P.

Cancers (Basel). 2019 Apr 13;11(4). pii: E531. doi: 10.3390/cancers11040531.

8.

Breathable hydrogel dressings containing natural antioxidants for management of skin disorders.

Comotto M, Saghazadeh S, Bagherifard S, Aliakbarian B, Kazemzadeh-Narbat M, Sharifi F, Mousavi Shaegh SA, Arab-Tehrany E, Annabi N, Perego P, Khademhosseini A, Tamayol A.

J Biomater Appl. 2019 Apr;33(9):1265-1276. doi: 10.1177/0885328218816526.

9.

KiSS1 in regulation of metastasis and response to antitumor drugs.

Corno C, Perego P.

Drug Resist Updat. 2019 Jan;42:12-21. doi: 10.1016/j.drup.2019.02.001. Epub 2019 Feb 11. Review.

PMID:
30776659
10.

Alterations of RNA Metabolism by Proteomic Analysis of Breast Cancer Cells Exposed to Marycin: A New Optically Active Porphyrin.

Taverna E, De Bortoli M, Maffioli E, Corno C, Ciusani E, Trivulzio S, Pinelli A, Tedeschi G, Perego P, Bongarzone I.

Curr Mol Pharmacol. 2019;12(2):147-159. doi: 10.2174/1874467212666190204102112.

PMID:
30714537
11.

Role of FoxO Proteins in Cellular Response to Antitumor Agents.

Beretta GL, Corno C, Zaffaroni N, Perego P.

Cancers (Basel). 2019 Jan 14;11(1). pii: E90. doi: 10.3390/cancers11010090. Review.

12.

Patterns of motorcycle helmet use - A naturalistic observation study in Myanmar.

Siebert FW, Albers D, Naing UA, Perego P, Santikarn C.

Accid Anal Prev. 2019 Mar;124:146-150. doi: 10.1016/j.aap.2019.01.011. Epub 2019 Jan 11.

PMID:
30639687
13.

Wearable textile based on silver plated knitted sensor for respiratory rate monitoring.

Molinaro N, Massaroni C, Lo Presti D, Saccomandi P, Di Tomaso G, Zollo L, Perego P, Andreoni G, Schena E.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:2865-2868. doi: 10.1109/EMBC.2018.8512958.

PMID:
30440999
14.

Tau Mutations as a Novel Risk Factor for Cancer-Response.

Rossi G, Redaelli V, Perego P, Ferrari R, Giaccone G, Tagliavini F.

Cancer Res. 2018 Nov 15;78(22):6525. doi: 10.1158/0008-5472.CAN-18-2730. Epub 2018 Oct 29. No abstract available.

15.

Immobilization of Aspergillus ficuum tannase in calcium alginate beads and its application in the treatment of boldo (Peumus boldus) tea.

de Lima JS, Cabrera MP, Casazza AA, da Silva MF, Perego P, de Carvalho LB Jr, Converti A.

Int J Biol Macromol. 2018 Oct 15;118(Pt B):1989-1994. doi: 10.1016/j.ijbiomac.2018.07.084. Epub 2018 Jul 20.

PMID:
30012487
16.

Tau Mutations Serve as a Novel Risk Factor for Cancer.

Rossi G, Redaelli V, Contiero P, Fabiano S, Tagliabue G, Perego P, Benussi L, Bruni AC, Filippini G, Farinotti M, Giaccone G, Buiatiotis S, Manzoni C, Ferrari R, Tagliavini F.

Cancer Res. 2018 Jul 1;78(13):3731-3739. doi: 10.1158/0008-5472.CAN-17-3175. Epub 2018 May 24.

17.

Optimization of spray drying conditions to microencapsulate cupuassu (Theobroma grandiflorum) seed by-product extract.

da Costa RS, Teixeira CB, Gabbay Alves TV, Ribeiro-Costa RM, Casazza AA, Aliakbarian B, Converti A, Silva Júnior JOC, Perego P.

Nat Prod Res. 2019 Sep;33(18):2600-2608. doi: 10.1080/14786419.2018.1462178. Epub 2018 Apr 16.

PMID:
29656659
18.

Cell protection from Ca2+-overloading by bioactive molecules extracted from olive pomace.

Averna M, Casazza AA, Martines A, Pedrazzi M, Franchi A, De Tullio R, Perego P, Melloni E.

Nat Prod Res. 2019 May;33(10):1449-1455. doi: 10.1080/14786419.2017.1422181. Epub 2018 Jan 4.

PMID:
29298502
19.

Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group.

Perego P, Hempel G, Linder S, Bradshaw TD, Larsen AK, Peters GJ, Phillips RM; EORTC PAMM Group.

Cancer Chemother Pharmacol. 2018 Mar;81(3):427-441. doi: 10.1007/s00280-017-3502-7. Epub 2017 Dec 28. Review.

PMID:
29285635
20.

Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7.

Misiak M, Heldt M, Szeligowska M, Mazzini S, Scaglioni L, Grabe GJ, Serocki M, Lica J, Switalska M, Wietrzyk J, Beretta GL, Perego P, Zietkowski D, Baginski M, Borowski E, Skladanowski A.

Oncotarget. 2017 Oct 10;8(62):105137-105154. doi: 10.18632/oncotarget.21806. eCollection 2017 Dec 1.

21.

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models.

Corno C, Stucchi S, De Cesare M, Carenini N, Stamatakos S, Ciusani E, Minoli L, Scanziani E, Argueta C, Landesman Y, Zaffaroni N, Gatti L, Perego P.

Biochem Pharmacol. 2018 Jan;147:93-103. doi: 10.1016/j.bcp.2017.11.009. Epub 2017 Nov 16.

PMID:
29155058
22.

Bioactive compounds and antioxidant potential for polyphenol-rich cocoa extract obtained by agroindustrial residue.

Gabbay Alves TV, Silva da Costa R, Aliakbarian B, Casazza AA, Perego P, Pinheiro Arruda MS, Carréra Silva Júnior JO, Converti A, Ribeiro Costa RM.

Nat Prod Res. 2019 Feb;33(4):589-592. doi: 10.1080/14786419.2017.1399381. Epub 2017 Nov 10.

PMID:
29126366
23.

Editorial: Targeting Drug-resistant and Metastatic Tumors by Interference with Tumor and Microenvironment-related Alterations.

Perego P.

Curr Med Chem. 2017;24(26):2808. doi: 10.2174/092986732426170914124127. No abstract available.

PMID:
28911301
24.

Polyphenolic extract attenuates fatty acid-induced steatosis and oxidative stress in hepatic and endothelial cells.

Vergani L, Vecchione G, Baldini F, Grasselli E, Voci A, Portincasa P, Ferrari PF, Aliakbarian B, Casazza AA, Perego P.

Eur J Nutr. 2018 Aug;57(5):1793-1805. doi: 10.1007/s00394-017-1464-5. Epub 2017 May 19.

PMID:
28526925
25.

Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.

Corno C, Gatti L, Arrighetti N, Carenini N, Zaffaroni N, Lanzi C, Perego P.

Biochem Pharmacol. 2017 Jul 15;136:40-50. doi: 10.1016/j.bcp.2017.04.002. Epub 2017 Apr 9.

PMID:
28404378
26.

Production, purification and characterization of an aspartic protease from Aspergillus foetidus.

Souza PM, Werneck G, Aliakbarian B, Siqueira F, Ferreira Filho EX, Perego P, Converti A, Magalhães PO, Junior AP.

Food Chem Toxicol. 2017 Nov;109(Pt 2):1103-1110. doi: 10.1016/j.fct.2017.03.055. Epub 2017 Mar 28.

PMID:
28359876
27.

Microencapsulation of Theobroma cacao L. waste extract: optimization using response surface methodology.

Gabbay Alves TV, Silva da Costa R, Aliakbarian B, Casazza AA, Perego P, Carréra Silva Júnior JO, Ribeiro Costa RM, Converti A.

J Microencapsul. 2017 Mar;34(2):111-120. doi: 10.1080/02652048.2017.1296499. Epub 2017 Mar 13.

PMID:
28288552
28.

Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.

Arosio D, Manzoni L, Corno C, Perego P.

Recent Pat Anticancer Drug Discov. 2017;12(2):148-168. doi: 10.2174/1574892812666170203151930. Review.

PMID:
28164756
29.

Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential.

Conconi D, Chiappa V, Perego P, Redaelli S, Bovo G, Lavitrano M, Milani R, Dalprà L, Lissoni AA.

Oncol Rep. 2017 Jan;37(1):41-47. doi: 10.3892/or.2016.5274. Epub 2016 Nov 24.

30.

RECQL4 Modulates MDR1 Expression and Chemoresistance-Letter.

Perego P.

Cancer Res. 2016 Dec 15;76(24):7290. Epub 2016 Dec 6. No abstract available.

31.

lncRNAs as Novel Indicators of Patients' Prognosis in Stage I Epithelial Ovarian Cancer: A Retrospective and Multicentric Study.

Martini P, Paracchini L, Caratti G, Mello-Grand M, Fruscio R, Beltrame L, Calura E, Sales G, Ravaggi A, Bignotti E, Odicino FE, Sartori E, Perego P, Katsaros D, Craparotta I, Chiorino G, Cagnin S, Mannarino L, Ceppi L, Mangioni C, Ghimenti C, D'Incalci M, Marchini S, Romualdi C.

Clin Cancer Res. 2017 May 1;23(9):2356-2366. doi: 10.1158/1078-0432.CCR-16-1402. Epub 2016 Nov 8.

32.

Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study.

Fiorentini C, Fragni M, Perego P, Vezzoli S, Bonini SA, Tortoreto M, Galli D, Claps M, Tiberio GA, Terzolo M, Missale C, Memo M, Procopio G, Zaffaroni N, Berruti A, Sigala S.

J Clin Endocrinol Metab. 2016 Dec;101(12):4594-4602. Epub 2016 Sep 14.

33.

PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells.

Arrighetti N, Cossa G, De Cecco L, Stucchi S, Carenini N, Corna E, Gandellini P, Zaffaroni N, Perego P, Gatti L.

Toxicol Appl Pharmacol. 2016 Nov 1;310:9-19. doi: 10.1016/j.taap.2016.08.005. Epub 2016 Aug 20.

PMID:
27554045
34.

A Smart Wearable Sensor System for Counter-Fighting Overweight in Teenagers.

Standoli CE, Guarneri MR, Perego P, Mazzola M, Mazzola A, Andreoni G.

Sensors (Basel). 2016 Aug 10;16(8). pii: E1220. doi: 10.3390/s16081220.

35.

Synthetic sulfoglycolipids targeting the serine-threonine protein kinase Akt.

Costa B, Dangate M, Vetro M, Donvito G, Gabrielli L, Amigoni L, Cassinelli G, Lanzi C, Ceriani M, De Gioia L, Filippi G, Cipolla L, Zaffaroni N, Perego P, Colombo D.

Bioorg Med Chem. 2016 Aug 15;24(16):3396-405. doi: 10.1016/j.bmc.2016.05.031. Epub 2016 May 18.

PMID:
27316541
36.

Defining Requirements and Related Methods for Designing Sensorized Garments.

Andreoni G, Standoli CE, Perego P.

Sensors (Basel). 2016 May 26;16(6). pii: E769. doi: 10.3390/s16060769.

37.

Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells.

Corno C, Gatti L, Lanzi C, Zaffaroni N, Colombo D, Perego P.

Curr Med Chem. 2016;23(15):1496-512. Review.

PMID:
27048336
38.

Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness.

Beretta GL, De Cesare M, Albano L, Magnifico A, Carenini N, Corna E, Perego P, Gatti L.

Tumori. 2016 Mar-Apr;102(2):144-9. doi: 10.5301/tj.5000471. Epub 2016 Feb 19.

PMID:
26917410
39.

A new bioenergetic and thermodynamic approach to batch photoautotrophic growth of Arthrospira (Spirulina) platensis in different photobioreactors and under different light conditions.

da Silva MF, Casazza AA, Ferrari PF, Perego P, Bezerra RP, Converti A, Porto AL.

Bioresour Technol. 2016 May;207:220-8. doi: 10.1016/j.biortech.2016.01.128. Epub 2016 Feb 6.

40.

An efficient liposome based method for antioxidants encapsulation.

Paini M, Daly SR, Aliakbarian B, Fathi A, Tehrany EA, Perego P, Dehghani F, Valtchev P.

Colloids Surf B Biointerfaces. 2015 Dec 1;136:1067-72. doi: 10.1016/j.colsurfb.2015.10.038. Epub 2015 Oct 31.

PMID:
26590900
41.

Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy.

Perego P, Robert J.

Cancer Chemother Pharmacol. 2016 Jan;77(1):5-18. doi: 10.1007/s00280-015-2901-x. Epub 2015 Nov 20. Review.

PMID:
26589793
42.

Developmental Dyslexia With and Without Language Impairment: ERPs Reveal Qualitative Differences in Morphosyntactic Processing.

Cantiani C, Lorusso ML, Perego P, Molteni M, Guasti MT.

Dev Neuropsychol. 2015;40(5):291-312. doi: 10.1080/87565641.2015.1072536.

PMID:
26285096
43.

Preface: histone deacetylases as therapeutic targets.

Perego P.

Crit Rev Oncog. 2015;20(1-2):2 pages before page 1. No abstract available.

PMID:
26277797
44.

Kinetic and thermodynamic studies of a novel acid protease from Aspergillus foetidus.

Souza PM, Aliakbarian B, Filho EX, Magalhães PO, Junior AP, Converti A, Perego P.

Int J Biol Macromol. 2015 Nov;81:17-21. doi: 10.1016/j.ijbiomac.2015.07.043. Epub 2015 Jul 23.

45.

Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.

Bertolini G, D'Amico L, Moro M, Landoni E, Perego P, Miceli R, Gatti L, Andriani F, Wong D, Caserini R, Tortoreto M, Milione M, Ferracini R, Mariani L, Pastorino U, Roato I, Sozzi G, Roz L.

Cancer Res. 2015 Sep 1;75(17):3636-49. doi: 10.1158/0008-5472.CAN-14-3781. Epub 2015 Jul 3.

46.

Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery.

Bianchi A, Arosio D, Perego P, De Cesare M, Carenini N, Zaffaroni N, De Matteo M, Manzoni L.

Org Biomol Chem. 2015 Jul 21;13(27):7530-41. doi: 10.1039/c5ob00497g.

PMID:
26074454
47.

Orchestration of DSB repair: a novel BRCA2 connection.

Gatti L, Perego P.

Cell Cycle. 2015;14(14):2195-6. doi: 10.1080/15384101.2015.1056614. Epub 2015 Jun 1. No abstract available.

PMID:
26029962
48.
49.

New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants.

Gatti L, Cassinelli G, Zaffaroni N, Lanzi C, Perego P.

Drug Resist Updat. 2015 May;20:1-11. doi: 10.1016/j.drup.2015.04.001. Epub 2015 May 7. Review.

PMID:
26003720
50.

Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.

Beltrame L, Di Marino M, Fruscio R, Calura E, Chapman B, Clivio L, Sina F, Mele C, Iatropoulos P, Grassi T, Fotia V, Romualdi C, Martini P, Noris M, Paracchini L, Craparotta I, Petrillo M, Milani R, Perego P, Ravaggi A, Zambelli A, Ronchetti E, D'Incalci M, Marchini S.

Ann Oncol. 2015 Jul;26(7):1363-71. doi: 10.1093/annonc/mdv164. Epub 2015 Apr 6.

Supplemental Content

Loading ...
Support Center